Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
- PMID: 12363453
- DOI: 10.1016/s0168-3659(02)00212-2
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
Abstract
The main objective of this study was to develop a polymeric drug delivery system for paclitaxel, intended to be intravenously administered, capable of improving the therapeutic index of the drug and devoid of the adverse effects of Cremophor EL. To achieve this goal paclitaxel (Ptx)-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles (Ptx-PLGA-Nps) were prepared by the interfacial deposition method. The influence of different experimental parameters on the incorporation efficiency of paclitaxel in the nanoparticles was evaluated. Our results demonstrate that the incorporation efficiency of paclitaxel in nanoparticles was mostly affected by the method of preparation of the organic phase and also by the organic phase/aqueous phase ratio. Our data indicate that the methodology of preparation allowed the formation of spherical nanometric (<200 nm), homogeneous and negatively charged particles which are suitable for intravenous administration. The release behaviour of paclitaxel from the developed Nps exhibited a biphasic pattern characterised by an initial fast release during the first 24 h, followed by a slower and continuous release. The in vitro anti-tumoral activity of Ptx-PLGA-Nps developed in this work was assessed using a human small cell lung cancer cell line (NCI-H69 SCLC) and compared to the in vitro anti-tumoral activity of the commercial formulation Taxol. The influence of Cremophor EL on cell viability was also investigated. Exposure of NCI-H69 cells to 25 microg/ml Taxol resulted in a steep decrease in cell viability. Our results demonstrate that incorporation of Ptx in nanoparticles strongly enhances the cytotoxic effect of the drug as compared to Taxol, this effect being more relevant for prolonged incubation times.
Similar articles
-
Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.Int J Pharm. 2004 Nov 22;286(1-2):147-56. doi: 10.1016/j.ijpharm.2004.08.008. Int J Pharm. 2004. PMID: 15501011
-
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9. J Control Release. 2009. PMID: 18950666
-
Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).Int J Nanomedicine. 2013;8:4315-26. doi: 10.2147/IJN.S51629. Epub 2013 Nov 7. Int J Nanomedicine. 2013. PMID: 24235829 Free PMC article.
-
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47. doi: 10.1016/s0169-409x(02)00228-4. Adv Drug Deliv Rev. 2003. PMID: 12628320 Review.
-
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.Int J Nanomedicine. 2011;6:877-95. doi: 10.2147/IJN.S18905. Epub 2011 May 27. Int J Nanomedicine. 2011. PMID: 21720501 Free PMC article. Review.
Cited by
-
The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs.Inorg Chem. 2013 Sep 3;52(17):9915-20. doi: 10.1021/ic4010642. Epub 2013 Jul 16. Inorg Chem. 2013. PMID: 23859129 Free PMC article.
-
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.Biomaterials. 2007 Feb;28(5):869-76. doi: 10.1016/j.biomaterials.2006.09.047. Epub 2006 Oct 20. Biomaterials. 2007. PMID: 17055572 Free PMC article.
-
Nanoparticles: pharmacological and toxicological significance.Br J Pharmacol. 2007 Mar;150(5):552-8. doi: 10.1038/sj.bjp.0707130. Epub 2007 Jan 22. Br J Pharmacol. 2007. PMID: 17245366 Free PMC article. Review.
-
Rapid Self-Assembly of Polymer Nanoparticles for Synergistic Codelivery of Paclitaxel and Lapatinib via Flash NanoPrecipitation.Nanomaterials (Basel). 2020 Mar 20;10(3):561. doi: 10.3390/nano10030561. Nanomaterials (Basel). 2020. PMID: 32244904 Free PMC article.
-
PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery.Indian J Med Res. 2016 Aug;144(2):181-193. doi: 10.4103/0971-5916.195024. Indian J Med Res. 2016. PMID: 27934796 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources